ARCHIVES

Pfizer’s Withdrawal Of Mylotarg Signals Stronger FDA Resolve To Monitor Confirmatory Studies

This article is from The Cancer Letter archive.

Vol. 36 No. 24 | June 25, 2010

Download PDF Visit The Full Archive

Related Articles

In Brief: David Tweardy named head of internal medicine at MD Anderson

September 19, 2014

In Brief: 896 Nurses Pass Oncology Certification Exam; ACS Awards 375 New Grants Worth $43.8 Million

July 6, 1990

NCI Cooperative Groups Begin Trial Of Individualized Rx For Breast Cancer

May 26, 2006

CCOP Reponses So Far Indicates application To Total 150-200

August 27, 1982

Guest Editorial by Robert Cook-Deegan: Myriad Case Ruling Likely to Concur With DOJ Arguments

April 19, 2013

Healy Sworn In, Calls For ‘Operation Bethesda Storm’

July 12, 1991